Literature DB >> 6737047

Intracarotid slow bolus injection of nimodipine during angiography for treatment of cerebral vasospasm after SAH. A preliminary report.

J A Grotenhuis, W Bettag, B J Fiebach, K Dabir.   

Abstract

Nimodipine was given as an intracarotid slow bolus injection in six patients with subarachnoid hemorrhage (SAH) due to rupture of a cerebral aneurysm, with angiographically demonstrated vasospasm. The patients were followed by serial angiograms for demonstration of the effect of nimodipine on vasospasm. After angiography, all patients were treated with a constant venous infusion of this new calcium antagonist. Although the therapeutic regimen was started only a few hours after onset of vasospasm, there was no change in cerebral vessel caliber detectable on angiograms following the intracarotid injection. Three patients died, two patients finally recovered with neurological deficits due to cerebral ischemia, and one patient with asymptomatic vasospasm remained symptom-free. Although nimodipine may act to prevent cerebral vasospasm after SAH, the authors believe that the intracarotid application is not effective after vasospasm has occurred.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6737047     DOI: 10.3171/jns.1984.61.2.0231

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  19 in total

1.  Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model.

Authors:  M Murat Firat; Veli Gelebek; Hakan S Orer; Deniz Belen; Ahmet K Firat; Ferhun Balkanci
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

2.  The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs.

Authors:  M Shibuya; Y Suzuki; M Takayasu; T Asano; T Harada; I Ikegaki; S Satoh; H Hidaka
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

Review 3.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

4.  Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage.

Authors:  M Shibuya; Y Suzuki; H Enomoto; T Okada; K Ogura; K Sugita
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

5.  The effect of nimodipine on autoregulation of cerebral blood flow after subarachnoid haemorrhage in rat.

Authors:  J Hauerberg; G Rasmussen; M Juhler; F Gjerris
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  Oral nimodipine reduces prostaglandin and thromboxane production by arteries chronically exposed to a periarterial haematoma and the antifibrinolytic agent tranexamic acid.

Authors:  J D Pickard; V Walker; J Vile; S Perry; P J Smythe; R Hunt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

7.  Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results.

Authors:  Alessandra Biondi; Giuseppe K Ricciardi; Louis Puybasset; Lamine Abdennour; Marcello Longo; Jacques Chiras; Rémy Van Effenterre
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

8.  Intraarterial nimodipine infusion to treat symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Jong Hoon Kim; In Sung Park; Kyung Bum Park; Dong-Ho Kang; Soo Hyun Hwang
Journal:  J Korean Neurosurg Soc       Date:  2009-09-30

9.  Effects of HA1077, an intracellular calcium antagonist, on neurotransmitter metabolism in rat brain in vivo.

Authors:  Y Kondoh; S Mizusawa; M Murakami; K Nagata; H Nakamichi; K Watanabe
Journal:  Metab Brain Dis       Date:  1991-09       Impact factor: 3.584

10.  Nimodipine-induced changes in the distribution of carotid blood flow and cardiac output in pentobarbitone-anaesthetized pigs.

Authors:  D J Duncker; J Heiligers; E J Mylecharane; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.